Radoslav Raychev, co-founder and Chief Executive Officer of Neuronics Medical, joins us at theCUBE Studios for a thought-provoking discussion on the promising advancements in Medical AI. This conversation occurs during the ACTAI Global Asia Pacific 2025 event, where Raychev shares insights as a finalist in the inaugural artificial intelligence startup competition, a pivotal milestone for both the global AI community and Neuronics Medical.
In this engaging video, join hosts John Furrier and theCUBE Research as they delve into the expertise of Raychev, a passionate advocate for transformative AI technologies in healthcare. Raychev's extensive background in stroke treatment offers a unique perspective on the challenges and opportunities in improving stroke diagnosis through AI. They share the mission of Neuronics Medical to revolutionize stroke detection and minimize the associated socio-economic impacts.
During the discussion, critical takeaways emerge, such as the "FAST" acronym for stroke detection - Facial asymmetry, Arm weakness, Speech changes, and Time to call emergency services. Raychev emphasizes the crucial role of timely detection in stroke treatment and highlights the financial and societal benefits of reducing stroke-related disabilities. According to them, Neuronics Medical aims to merge advanced AI algorithms into consumer devices and Emergency Medical Services systems to achieve these goals.
Forgot Password
Almost there!
We just sent you a verification email. Please verify your account to gain access to
theCUBE + NYSE Wired: Actai Global. If you don’t think you received an email check your
spam folder.
In order to sign in, enter the email address you used to registered for the event. Once completed, you will receive an email with a verification link. Open this link to automatically sign into the site.
Register For theCUBE + NYSE Wired: Actai Global
Please fill out the information below. You will recieve an email with a verification link confirming your registration. Click the link to automatically sign into the site.
You’re almost there!
We just sent you a verification email. Please click the verification button in the email. Once your email address is verified, you will have full access to all event content for theCUBE + NYSE Wired: Actai Global.
I want my badge and interests to be visible to all attendees.
Checking this box will display your presense on the attendees list, view your profile and allow other attendees to contact you via 1-1 chat. Read the Privacy Policy. At any time, you can choose to disable this preference.
Select your Interests!
add
Upload your photo
Uploading..
OR
Connect via Twitter
Connect via Linkedin
EDIT PASSWORD
Share
Forgot Password
Almost there!
We just sent you a verification email. Please verify your account to gain access to
theCUBE + NYSE Wired: Actai Global. If you don’t think you received an email check your
spam folder.
In order to sign in, enter the email address you used to registered for the event. Once completed, you will receive an email with a verification link. Open this link to automatically sign into the site.
Sign in to gain access to theCUBE + NYSE Wired: Actai Global
Please sign in with LinkedIn to continue to theCUBE + NYSE Wired: Actai Global. Signing in with LinkedIn ensures a professional environment.
Are you sure you want to remove access rights for this user?
Details
Manage Access
email address
Community Invitation
Radoslav Raychev, Neuronics Medical AI
Radoslav Raychev, co-founder and Chief Executive Officer of Neuronics Medical, joins us at theCUBE Studios for a thought-provoking discussion on the promising advancements in Medical AI. This conversation occurs during the ACTAI Global Asia Pacific 2025 event, where Raychev shares insights as a finalist in the inaugural artificial intelligence startup competition, a pivotal milestone for both the global AI community and Neuronics Medical.
In this engaging video, join hosts John Furrier and theCUBE Research as they delve into the expertise of Raychev, a passionate advocate for transformative AI technologies in healthcare. Raychev's extensive background in stroke treatment offers a unique perspective on the challenges and opportunities in improving stroke diagnosis through AI. They share the mission of Neuronics Medical to revolutionize stroke detection and minimize the associated socio-economic impacts.
During the discussion, critical takeaways emerge, such as the "FAST" acronym for stroke detection - Facial asymmetry, Arm weakness, Speech changes, and Time to call emergency services. Raychev emphasizes the crucial role of timely detection in stroke treatment and highlights the financial and societal benefits of reducing stroke-related disabilities. According to them, Neuronics Medical aims to merge advanced AI algorithms into consumer devices and Emergency Medical Services systems to achieve these goals.
Radoslav Raychev, co-founder and Chief Executive Officer of Neuronics Medical, joins us at theCUBE Studios for a thought-provoking discussion on the promising advancements in Medical AI. This conversation occurs during the ACTAI Global Asia Pacific 2025 event, where Raychev shares insights as a finalist in the inaugural artificial intelligence startup competition, a pivotal milestone for both the global AI community and Neuronics Medical.
In this engaging video, join hosts John Furrier and theCUBE Research as they delve into the expertise of Raychev,...Read more
